S. Dahmen, S. Bra¨se / Tetrahedron: Asymmetry 12 (2001) 2845–2850
2849
(t), 132.74 (t), 133.96 (t), 134.02 (t), 137.26 (q), 138.35
(q), 140.60 (q), 144.43 (q), 155.71 (q, C-4) ppm; IR
(KBr): w=3309 (OH), 1593, 1566, 1430 cm−1; MS (70
eV, EI), m/z (%): 371 (100) [M+], 145 (96), 104 (97);
HRMS C26H29NO calcd: 371.2249, found: 371.2250.
127.11 (t), 127.57 (t), 127.68 (q), 128.79 (t), 129.16 (t),
132.43 (t), 133.77 (t), 134.11 (t), 136.92 (q), 138.22 (q),
140.21 (q), 142.86 (q), 155.34 (q, C-4) ppm; IR (KBr):
w=3309 (OH), 1593, 1565, 1430 cm−1; MS (70 eV, EI),
m/z (%): 371 (94) [M+], 145 (100), 105 (31), 104 (99);
HRMS C26H29NO calcd: 371.2249, found: 371.2249.
4.2.4. (Sp,S,S)-5-[Phenyl-(1%-phenylethylamino)methyl]-4-
hydroxy[2.2]paracyclophane 12. To a solution of (Sp,S)-
5-[phenyl-(1%-phenylethylimino)methyl]-4-hydroxy[2.2]-
paracyclophane (Sp,S)-9 (100 mg, 0.23 mmol) in etha-
nol (10 mL) was added at rt NaBH4 (38 mg, 1 mmol)
and the mixture was stirred for 2 h. After quenching
with water, the mixture was extracted with dichloro-
methane and the combined organic layers were dried
over MgSO4. After removal of the solvent, the title
compound was obtained as a yellow oil (98 mg,
4.4. Reductive amination
4.4.1.
(Sp)-5-[(Dibenzylamino)methyl]-4-hydroxy[2.2]-
paracyclophane (Sp)-14. To a solution of (Sp)-5-formyl-
4-hydroxy[2.2]paracyclophane (Sp)-4 (72 mg, 0.28
mmol) in methanol (10 mL) was added dibenzylamine
(274 mg, 1.4 mmol) and 5 M HCl (100 mL) at rt. After
stirring for 0.5 h, Na(CN)BH3 (21 mg, 0.33 mmol) was
added and the mixture was stirred for a further 2 h. The
mixture was quenched with water, neutralized with
NaHCO3 solution and extracted several times with
dichloromethane. After chromatography on silica (1.7×
20 cm, dichloromethane), the title compound was
obtained as a white solid (100 mg, 82%): Rf=0.58
1
98%): major diastereomer (d.e.=78%); H NMR (400
MHz, CDCl3): l 1.63 (d, J=6.6 Hz, 3H, CH3), 2.41–
2.51 (m, 1H), 2.54–2.64 (m, 1H), 2.73–2.92 (m, 2H),
3.00–3.23 (m, 3H), 3.39–3.47 (m, 1H, C-1, C-2, C-9,
C-10), 4.00 (q, br, J=6.6 Hz, 1H, NCH(CH3)Ph), 4.86
(s, 1H, pcCH(Ph)N), 5.97 (d, J=7.4 Hz, 1H), 6.30 (d,
J=7.7 Hz, 1H), 6.52 (dd, J=8.0 Hz, 1.6 Hz, 1H), 6.61
(dd, J=7.7 Hz, 1.9 Hz, 1H), 6.78 (dd, J=7.7 Hz, 1.9
Hz, 1H), 6.97–7.02 (m, 2H, HAr), 7.04 (dd, J=7.7 Hz,
1.6 Hz, 1H, Hpc), 7.12–7.40 (m, 8H, HAr) ppm; 13C
NMR (100 MHz, CDCl3): l 22.25 (p, NCH(CH3)Ph),
29.99 (s), 33.69 (s), 34.02 (s), 34.17 (s, C-1, C-2, C-9,
C-10), 55.20 (t, NCH(CH3)Ph), 62.89 (t, pcCH(Ph)N),
123.66 (q), 125.79 (t), 126.26 (t), 126.31 (t), 127.08 (t),
127.19 (t), 127.36 (t), 127.43 (t), 127.65 (q), 128.50 (t),
128.65 (t), 128.68 (t), 132.30 (t), 133.68 (t), 138.04 (q),
138.65 (t), 140.25 (q), 143.16 (q), 143.50 (q), 156.75 (q,
C-4) ppm.
1
(dichloromethane); [h]2D0=−93 (c 1.0, CHCl3); H NMR
(400 MHz, CDCl3): l 2.43–2.58 (m, 2H, Hpc), 2.61–2.70
(m, 1H, Hpc), 2.91–3.01 (m, 3H, Hpc), 3.10 (d, J=13.2
Hz, 2H, NCH2Ph), 3.18 (d, J=14.6 Hz, 1H, NCH2pc),
3.28–3.36 (m, 1H, Hpc), 3.39 (d, J=14.3 Hz, 1H,
NCH2pc), 3.95 (d, J=12.9 Hz, 2H, NCH2Ph), 5.84 (d,
J=8.0 Hz, 1H, Hpc), 6.11 (d, J=7.7 Hz, 1H, Hpc), 6.33
(d, br, J=7.7 Hz, 1H, Hpc), 6.40 (d, J=7.7 Hz, 1H,
Hpc), 6.41 (m, br, 2H, Hpc), 7.27–7.42 (m, 10H, HAr)
ppm; 13C NMR (100 MHz, CDCl3): l 30.35, 33.10,
34.14, 34.18 (C-1, C-2, C-9, C-10), 53.87 (C-17), 58.82
(C-18), 121.21 (q), 124.61 (t), 125.92 (q), 126.14 (t),
127.43 (t, all C-Arpc), 128.01 (t), 128.86 (t), 130.00 (t, all
C-Ar), 132.40 (t), 132.87 (t), 133.04 (t, all C-Arpc),
137.06 (q), 137.16 (q), 139.78 (q), 140.01 (q), 156.55
(C-4) ppm; IR (KBr): w=3026, 1599, 1566, 1497, 1447,
1431 cm−1; MS (70 eV, EI), m/z (%): 433 (100) [M+],
329 (51), 238 (21), 196 (20), 106 (23), 104 (64), 91 (54);
HRMS C31H31NO calcd: 433.2406, found: 433.2406.
4.3. 1,2-Addition to imines
4.3.1.
hydroxy[2.2]paracyclophane (Sp,S,R)-11. To a solution
of (Sp,S)-5-[(1%-phenylethylimino)methyl]-4-hydroxy-
(Sp,S,R)-5-[1%-(1¦-Phenylethylamino)ethyl]-4-
[2.2]paracyclophane (Sp,S)-5 (55 mg, 0.15 mmol) in
THF (10 mL) was added at −78°C methyllithium (1
mL, 5% in Diethylether, 1.6 mmol) under argon. The
solution was allowed to warm to rt over 15 h. The
mixture was quenched with water and extracted with
dichloromethane. After drying over MgSO4 and
removal of the solvent, the title compound was
obtained as a white solid (50 mg, 84%): Rf=0.33 (pen-
4.4.2.
(Rp)-5-[(Benzylmethylamino)methyl]-4-hydroxy-
[2.2]paracyclophane (Rp)-15. To a solution of (Rp)-5-for-
myl-4-hydroxy[2.2]paracyclophane (Rp)-4 (100 mg, 0.40
mmol) in 10 mL of methanol was added at rt methyl-
benzylamine (242 mg, 2.0 mmol) and conc. HCl (80
mL). After stirring for 0.5 h, Na(CN)BH3 (50 mg, 0.80
mmol) was added and the mixture was stirred for a
further 2 h at rt. The mixture was quenched with water,
neutralized with NaHCO3 solution and extracted sev-
eral times with dichloromethane. After chromatography
on neutral aluminum oxide (1.7×20 cm, pentane/
ether=9:1), the title compound was obtained as a white
solid (50 mg, 35%): Rf=0.6 (pentane/ether=9:1, neu-
1
tane/ether=1:1); [h]2D0=−140 (c 1.0, CHCl3); H NMR
(400 MHz, CDCl3): l 1.10 (d, J=6.3 Hz, 3H,
NCH(CH3)Ph), 1.59 (d, J=6.6 Hz, 3H, pcCH(CH3)N),
2.50–2.63 (m, 3H), 2.84–2.93 (m, 1H), 2.97–3.07 (m,
2H), 3.10–3.18 (m, 1H), 3.39–3.47 (m, 1H), 3.73 (q,
J=6.6 Hz, 1H, NCH(CH3)Ph), 3.99 (q, br, J=6.3 Hz,
1H, pcCH(CH3)N), 6.05 (d, J=7.7 Hz, 1H), 6.20 (dd,
J=8.0 Hz, 1.9 Hz, 1H), 6.28 (d, J=7.7 Hz, 1H), 6.46
(dd, J=8.0 Hz, 1.9 Hz, 1H), 6.56 (dd, J=8.0 Hz, 1.9
Hz, 1H), 7.33–7.51 (m, 5H, HAr) ppm; 13C NMR (100
MHz, CDCl3): l 20.29 (p, NCH(CH3)Ph), 24.29 (p,
pcCH(CH3)N), 30.08 (s), 32.92 (s), 33.96 (s), 34.45 (s,
C-1, C-2, C-9, C-10), 51.31 (t, pcCH(CH3)N), 53.98 (t,
NCH(CH3)Ph), 125.91 (q), 126.25 (t), 126.27 (q),
1
tral alox); [h]2D0=+132 (c 1.6, CHCl3); H NMR (400
MHz, CDCl3): l 2.18 (s, 3H, CH3), 2.51–2.74 (m, 3H),
2.94–3.08 (m, 4H), 3.24 (d, J=14.0 Hz, 1H, NCH2Ar),
3.28–3.36 (m, 2H), 3.38 (d, J=14.0 Hz, 1H, NCH2Ar),
3.74 (d, J=12.6 Hz, 1H, NCH2Ar), 6.11 (d, J=7.7 Hz,
1H), 6.28 (d, br, J=7.7 Hz, 1H), 6.41 (d, J=7.7 Hz,
1H), 6.47 (s, br, 2H), 6.66 (d, br, J=8.0 Hz, 1H),
7.27–7.40 (m, 5H, HAr) ppm; 13C NMR (100 MHz,
CDCl3): l 29.96, 32.78, 34.15 (C-1, C-2, C-9, C-10),